Concepedia

Kate L. Dixon

KL

4

Publications

231

Citations

4

H-Index

2014

Active since

Affiliations

UCB Pharma (United Kingdom)(Current)

Kate L. Dixon is an author at UCB Pharma (United Kingdom) specializing in autoimmunity, autoantibodies, and allergy.

Top concepts

Publications per year

2014–2021

4

Publications

4

Generation and characterization of a high affinity anti-human FcRn antibody, rozanolixizumab, and the effects of different molecular formats on the reduction of plasma IgG concentration

Bryan Smith, Rocío Lledó‐García, Kate L. Dixon et al. · mAbs · 2018 · 110 citations · Full text

, , +18

Alveolar macrophages are sentinels of murine pulmonary homeostasis following inhaled antigen challenge

Sara A. Mathie, Kate L. Dixon, Simone A. Walker et al. · Allergy · 2014 · 77 citations · Full text

OX40 blockade inhibits house dust mite driven allergic lung inflammation in mice and in vitro allergic responses in humans

Katie E. Burrows, Céline Dumont, Clare L. Thompson et al. · European Journal of Immunology · 2014 · 27 citations · Full text

Pharmacokinetic‐pharmacodynamic modelling of the anti‐FcRn monoclonal antibody rozanolixizumab: Translation from preclinical stages to the clinic

Rocío Lledó‐García, Kate L. Dixon, Anthony Shock et al. · CPT Pharmacometrics & Systems Pharmacology · 2021 · 17 citations · Full text

Rows per page

1–4 of 4